Skip to content
thispeptide

AJ Peptide

AJ Peptide describes prescription-only care through licensed providers and compounding pharmacies. Its documentation promises need to be matched to the actual product, pharmacy and assigned clinician.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

Request the dispensing business and a certificate tied to your supplied preparation. Neither a supplier registration nor a testing claim establishes FDA approval or clinical benefit.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

AJ Peptide LLC presents a provider-reviewed prescription service rather than a research-use-only storefront. Its current catalog names semaglutide, tirzepatide, sermorelin, tesamorelin, NAD and glutathione. The pages also offer a microdose GLP-1 category without identifying one ingredient in that label. Each treatment requires its own assessment. A broad metabolic or healthy-aging category does not establish that every product fits the same patient.

What AJ Peptide prescribes, by goal

Weight

  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    • TirzepatideFDA-approved

      Listed by the seller; no price we hold.

      The catalog separates ordinary semaglutide and tirzepatide from a microdose GLP-1 offer. The microdose label alone does not identify the preparation or establish a validated treatment schedule. Ask what is prescribed and why.

      Longevity

      • NAD+Compounding conditions apply

        Listed by the seller; no price we hold.

        • GlutathioneCompounding conditions apply

          Listed by the seller; no price we hold.

          Recovery

          • SermorelinCompounding conditions apply

            Listed by the seller; no price we hold.

            Sleep

            • SermorelinCompounding conditions apply

              Listed by the seller; no price we hold.

              Sermorelin is advertised for growth-hormone support and recovery. Those claims do not establish treatment of a particular sleep disorder or predict an individual result. Ask what benefit is being measured.

              Who prescribes

              A licensed clinician

              The site does not name the assigned clinician or professional practice. It describes licensed medical providers. They say pharmacy partners are licensed United States 503A businesses without identifying the assigned dispensing location in the treatment description. Ask for both identities before proceeding. The promise to identify a pharmacy is useful, but it is not the same as already knowing which pharmacy fills your prescription.

              A questionnaire and medical-history form precede provider evaluation. The provider then decides whether treatment is appropriate, followed by approval and delivery when prescribed. The public treatment pages do not establish one visit format or follow-up interval. Ask whether a synchronous consultation is available, how symptoms are reviewed and how medication questions reach the prescriber. Delivery alone does not establish ongoing clinical monitoring.

              Are labs required?

              Not mentioned

              Certificates of Analysis concern product testing and are different from a patient’s laboratory evaluation. Ask whether baseline tests are required, who interprets them and whether repeat tests have a separate cost. Published promises about sterility, endotoxins and potency do not establish an individual monitoring plan.

              Ready to start with AJ Peptide?

              Prices and plans are set on the seller's own site.

              What it claims, and what it cites

              The site emphasizes testing and sourcing documentation while acknowledging that compounded medications are not FDA-approved. Ask for the actual report, batch identity, testing date and responsible pharmacy. A registration claim about an ingredient supplier is not approval of the finished preparation. Manufacturing experience also does not establish the qualifications of the person prescribing. Clinical suitability remains a separate question.

              Other products and treatment claims

              Tesamorelin
              Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
              Vitamins and lipotropic combinations
              Their presence is not evidence of another relevant peptide preparation or inclusion within a selected prescription.

              How it bills

              The treatment cards show coupon amounts beside original prices without establishing one common supplied quantity or refill interval. Obtain those details with the full renewal charge. The refund policy says processed charges are nonrefundable, with limited exceptions for errors. It permits stopping future subscriptions before the next billing date. Canceling future charges does not itself reverse payment already processed.

              For and against

              • For: Prescription evaluation required before fulfillment
              • For: Compounded approval status disclosed explicitly
              • For: Product-testing documentation emphasized publicly
              • For: Future subscription stopping method described
              • Against: Assigned professional not identified publicly
              • Against: Dispensing pharmacy requires confirmation
              • Against: No universal follow-up schedule established
              • Against: Catalog price lacks common supply interval

              The evidence behind what it sells

              Right for

              Someone who will request product documentation and verify the clinical and pharmacy identities before treatment.

              Look elsewhere if

              Someone treating sourcing claims as proof of treatment effectiveness or assuming every catalog amount covers one month.

              Other sellers for weight

              AJ Peptide

              Frequently asked questions

              Does a Certificate of Analysis replace patient laboratory testing?
              No. Product testing and assessment of a patient’s health answer different questions.
              Are the finished compounded medications FDA-approved?
              The site says they are not. A supplier or pharmacy registration does not change that.
              Is a specific administration route established for every catalog product?
              No. Confirm the actual preparation and route rather than inferring them from a treatment category.

              Sources

              • Prescription model, operator and documentation promises
              • Metabolic treatment catalog and review process
              • Sermorelin and body-composition catalog
              • NAD and glutathione treatment catalog
              • Subscription cancellation and refunds
              • Platform terms and clinical relationship

              See what AJ Peptide prescribes today

              AJ Peptide sets its own prices, plans and the states it serves. Check them before you start.

              Written by Molly Ward from AJ Peptide’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.